ES8502865A1 - Procedimiento para producir una composicion farmaceutica nasal mejorada. - Google Patents

Procedimiento para producir una composicion farmaceutica nasal mejorada.

Info

Publication number
ES8502865A1
ES8502865A1 ES519450A ES519450A ES8502865A1 ES 8502865 A1 ES8502865 A1 ES 8502865A1 ES 519450 A ES519450 A ES 519450A ES 519450 A ES519450 A ES 519450A ES 8502865 A1 ES8502865 A1 ES 8502865A1
Authority
ES
Spain
Prior art keywords
medicinal composition
carbon dioxide
agent capable
ciliary function
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES519450A
Other languages
English (en)
Spanish (es)
Other versions
ES519450A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of ES519450A0 publication Critical patent/ES519450A0/es
Publication of ES8502865A1 publication Critical patent/ES8502865A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ES519450A 1982-02-01 1983-02-01 Procedimiento para producir una composicion farmaceutica nasal mejorada. Expired ES8502865A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8202781 1982-02-01

Publications (2)

Publication Number Publication Date
ES519450A0 ES519450A0 (es) 1985-02-01
ES8502865A1 true ES8502865A1 (es) 1985-02-01

Family

ID=10528017

Family Applications (1)

Application Number Title Priority Date Filing Date
ES519450A Expired ES8502865A1 (es) 1982-02-01 1983-02-01 Procedimiento para producir una composicion farmaceutica nasal mejorada.

Country Status (27)

Country Link
JP (1) JPS58134017A (enExample)
AT (1) AT385656B (enExample)
AU (1) AU565613B2 (enExample)
BE (1) BE895750A (enExample)
CA (1) CA1197783A (enExample)
CH (1) CH653555A5 (enExample)
DE (1) DE3302949A1 (enExample)
DK (1) DK164771C (enExample)
ES (1) ES8502865A1 (enExample)
FI (1) FI81258C (enExample)
FR (1) FR2539994B1 (enExample)
GR (1) GR81320B (enExample)
HK (1) HK59989A (enExample)
HU (1) HU191512B (enExample)
IE (1) IE54532B1 (enExample)
IL (1) IL67822A (enExample)
IT (1) IT1197558B (enExample)
KE (1) KE3888A (enExample)
LU (1) LU84613A1 (enExample)
MY (1) MY8700766A (enExample)
NL (1) NL192325C (enExample)
NZ (1) NZ203117A (enExample)
PH (1) PH22198A (enExample)
PT (1) PT76166B (enExample)
SE (1) SE454402B (enExample)
SG (1) SG34389G (enExample)
ZA (1) ZA83673B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0715285D0 (en) * 2007-08-06 2007-09-12 Britannia Pharmaceuticals Ltd Improvements in or relating to powdered medicaments for nasal delivery
GB0910375D0 (en) * 2009-06-16 2009-07-29 Biocopea Ltd Drug composition and its use in therapy
RU2020125871A (ru) * 2018-01-05 2022-02-07 Импел Ньюрофарма, Инк. Интраназальная доставка дигидроэрготамина с помощью прецизионного устройства для доставки в обонятельную область

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3091569A (en) * 1960-08-26 1963-05-28 Mead Johnson & Co Mucolytic-nu-acylated sulfhydryl compositions and process for treating animal mucus
GB1202885A (en) * 1966-12-22 1970-08-19 Sandoz Ltd Pharmaceutical compositions comprising alkaloids
DE2750090A1 (de) * 1976-11-19 1978-06-01 Sandoz Ag Neue verabreichungsformen fuer organische verbindungen
FR2387035A1 (fr) * 1977-04-12 1978-11-10 Cassenne Lab Sa Nouveau medicament destine notamment au traitement des troubles fonctionnels cerebraux
DE2831728C2 (de) * 1978-07-19 1982-12-23 Krewel-Werke Gmbh, 5208 Eitorf Arzneimittel zur Behandlung von Kopfschmerzen

Also Published As

Publication number Publication date
PH22198A (en) 1988-06-28
SG34389G (en) 1989-09-22
IL67822A0 (en) 1983-06-15
AU1085083A (en) 1983-08-11
HU191512B (en) 1987-02-27
FI81258B (fi) 1990-06-29
ATA30383A (de) 1987-10-15
DK164771B (da) 1992-08-17
HK59989A (en) 1989-08-04
DK38183D0 (da) 1983-01-31
NL192325C (nl) 1997-06-04
JPH0253406B2 (enExample) 1990-11-16
CA1197783A (en) 1985-12-10
CH653555A5 (de) 1986-01-15
AU565613B2 (en) 1987-09-24
IT8347646A0 (it) 1983-02-01
DK38183A (da) 1983-08-02
MY8700766A (en) 1987-12-31
KE3888A (en) 1989-09-01
DE3302949C2 (enExample) 1992-05-21
FR2539994A1 (fr) 1984-08-03
PT76166B (en) 1986-02-04
LU84613A1 (fr) 1983-09-08
SE454402B (sv) 1988-05-02
AT385656B (de) 1988-05-10
IL67822A (en) 1988-02-29
SE8300495L (sv) 1983-08-02
ZA83673B (en) 1984-09-26
DK164771C (da) 1992-12-28
FI81258C (fi) 1990-10-10
FR2539994B1 (fr) 1986-10-10
ES519450A0 (es) 1985-02-01
NL192325B (nl) 1997-02-03
SE8300495D0 (sv) 1983-01-31
IT1197558B (it) 1988-12-06
FI830245A0 (fi) 1983-01-25
JPS58134017A (ja) 1983-08-10
NZ203117A (en) 1986-12-05
FI830245L (fi) 1983-08-02
NL8300325A (nl) 1983-09-01
IT8347646A1 (it) 1984-08-01
GR81320B (enExample) 1984-12-11
DE3302949A1 (de) 1983-08-11
PT76166A (en) 1983-02-01
IE830187L (en) 1983-08-01
IE54532B1 (en) 1989-11-08
BE895750A (fr) 1983-08-01

Similar Documents

Publication Publication Date Title
ATE80548T1 (de) Medizinischer fluessigkeitsbehaelter und dessen herstellung.
GB1525448A (en) Dialysis membrane for haemodialysis
IT7849462A0 (it) Corpo di capsula in particolare per una capsula per la somministrazione di sostanze medicamentose come pure procedimento e dispositivo per lasua produzione
BR9809177A (pt) Comprimidos, e processo para fabricação de comprimidos
NO802843L (no) Fremgangsmaate for fremstilling av aktivt karbon i fibroes form
ES8201419A1 (es) Un metodo para preparar una solucion acuosa de nitrogliceri-na
PH12784A (en) 5-droxy-5-fluorocytidine,5-deoxy-5-fluorouridine and pharmaceutically acceptable acid addition salts thereof
IT8020245A0 (it) Procedimento e dispositivo perl'azionamento di un corpo rigido in modo da ottenere pure il movimento oscillante durante il movimento di rotazione del corpo stesso.
EA200200151A1 (ru) Сухая порошкообразная композиция
FR2347134A1 (fr) Procede de fabrication de corps en metaux frittes notamment d'electrodes de batteries
ATA661577A (de) Verfahren zur herstellung von neuen, optisch akti-ven 3-azabicyclo(3.1.0)hexanderivaten und ihren nichttoxischen, pharmazeutisch vertraeglichen salzen
ES8502865A1 (es) Procedimiento para producir una composicion farmaceutica nasal mejorada.
ZA80647B (en) Active electrode,electrochemical cell comprising the electrode and method of forming electrode
JPS6434909A (en) Cosmetic
NZ237513A (en) Retinoic acid esters, preparation and pharmaceutical/cosmetic compositions thereof
IE38028L (en) Compositions having a physiological cooling effect
DE3586457D1 (de) Solubilisierungsverfahren im moment der anwendung eines aktiven lipophilen prinzipes in waessriger loesung zum zweck der intravenoesen verabreichung.
SE8101963L (sv) Monohydrerad isoftalsyrapikolylamid, forfarande for dess framstellning samt farmaceutisk anvendning derav
IE831551L (en) Eye ointment.
HU177758B (en) Selective herbicide composition containing diurethane as active agent,and process for producing the active agent
USD221365S (en) Medical diagnostic console
ES2017935B3 (es) Derivado del acido 4-metoxi-isoftalico que tiene una actividad farmacologica en las afecciones tromboembolicas, y un procedimiento para su preparacion.
JPS52148615A (en) Aqueous biologically active solution
GR77250B (enExample)
IE46070L (en) Bronchial spasm and respiratory relief

Legal Events

Date Code Title Description
PC1A Transfer granted